4D Molecular Therapeutics (FDMT) Shares Issued (2020 - 2026)

4D Molecular Therapeutics (FDMT) has 6 years of Shares Issued data on file, last reported at $9.7 million in Q1 2026.

• Shares Issued for Q1 2026 came in at $9.7 million, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $9.7 million (up 149.68% YoY), and the FY2025 annual result was $9.6 million, down 37.25% from the prior year.
• Shares Issued grew to $9.7 million in Q1 2026 per FDMT's latest filing, from $37000.0 in the prior quarter.
• Over five years, Shares Issued peaked at $34.9 million in Q1 2024 and troughed at -$19.6 million in Q2 2024.
• A 4-year average of $4.4 million and a median of $1.1 million in 2022 frame the typical range for Shares Issued.
• On a YoY basis, Shares Issued climbed as much as 3600.0% in 2024 and fell as far as 338.57% in 2024.
• A 4-year view of Shares Issued shows it stood at -$875000.0 in 2022, then jumped by 100.11% to $1000.0 in 2023, then surged by 3600.0% to $37000.0 in 2024, then soared by 26116.22% to $9.7 million in 2026.
• Business Quant data shows FDMT's Shares Issued at $9.7 million in Q1 2026, $37000.0 in Q4 2024, and -$19.6 million in Q2 2024.